[1]
Ahasan, M.H. , Mahmood, M. , Adhikary, D.K. , Ahsan, S.A. , Ahmed, C.M. , Salim, M.A. , Ahmed, K. , Amin, M.R. , Khaled, M.F.I. , Singha, C.K. , Islam, R. , Ansari, S. , Biswas, S.K. , Karna, R. and Banerjee, S.K. 2022. Comparison of Safety and Efficacy Between Dabigatran and Rivaroxaban in Nonvalvular Atrial Fibrillation in Tertiary Level Hospital. University Heart Journal. 18, 1 (Jan. 2022), 10–13. DOI:https://doi.org/10.3329/uhj.v18i1.57874.